Fahir Özkalemkaş

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 366 citations

Hematological Malignancy, Relapsed Multiple Myeloma, Medicine +11

The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: A clinical study of 19 cases

Fahir Özkalemkaş, Rıdvan Ali, Vildan Özkocaman et al. · BMC Cancer · 2005 · 128 citations · Full text

Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes

Vildan Özkocaman, Tülay Özçelik, Fahir Özkalemkaş et al. · Journal of Hospital Infection · 2006 · 112 citations

Healthcare-associated Infection, Clinical Epidemiology, Clinical Features +7

Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML)

Rıdvan Ali, Fahir Özkalemkaş, Tülay Özçelik et al. · Leukemia Research · 2005 · 52 citations

Successful Labor, Infertility, Fertility +13

Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years

Rıdvan Ali, Fahir Özkalemkaş, Tülay Özçelik et al. · Leukemia Research · 2003 · 44 citations

Family Medicine, Single Institutional Experience, Medicine +10